Cargando…
Creatine kinase‐MM concentration in dried blood spots from newborns and implications for newborn screening for Duchenne muscular dystrophy
INTRODUCTION/AIMS: Creatine kinase‐MM (CK‐MM) is a marker of skeletal muscle damage. Detection of elevated levels of CK‐MM in newborns can enable an early suspicion of the diagnosis of Duchenne muscular dystrophy (DMD) before symptom onset. Our aim was to investigate CK‐MM levels in DMD‐affected and...
Autores principales: | Park, Sunju, Maloney, Breanne, Caggana, Michele, Tavakoli, Norma P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9322420/ https://www.ncbi.nlm.nih.gov/pubmed/35307847 http://dx.doi.org/10.1002/mus.27533 |
Ejemplares similares
-
Evaluation of the GSP Creatine Kinase-MM Assay and Assessment of CK-MM Stability in Newborn, Patient, and Contrived Dried Blood Spots for Newborn Screening for Duchenne Muscular Dystrophy
por: Migliore, Brooke A., et al.
Publicado: (2022) -
Multi-Laboratory Evaluation of Prototype Dried Blood Spot Quality Control Materials for Creatine Kinase-MM Newborn Screening Assays
por: Dantonio, Paul, et al.
Publicado: (2023) -
Newborn screening for Duchenne muscular dystrophy‐early detection and diagnostic algorithm for female carriers of Duchenne muscular dystrophy
por: Gruber, Dorota, et al.
Publicado: (2022) -
Newborn screening for Duchenne muscular dystrophy: A two‐year pilot study
por: Tavakoli, Norma P., et al.
Publicado: (2023) -
Newborn Screening for Duchenne Muscular Dystrophy: First Year Results of a Population-Based Pilot
por: Hartnett, Michael J., et al.
Publicado: (2022)